New-onset Chronic Pelvic Pain in Transgender People Using Testosterone Therapy: an Exploratory Qualitative Study.
RecruitingNCT06487754
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This descriptive qualitative study aim to describe the characteristics of pelvic pain in transgender (trans) individuals using testosterone therapy and the impact on their quality of life. This study also aim to understand the levers and obstacles to consulting a health care professional.
Study details
- Official title
- New-onset Chronic Pelvic Pain in Transgender People Using Testosterone Therapy: an Exploratory Qualitative Study.
- Conditions
- Transgender Persons
- Pelvic Pain
- Testosterone
- Gender-Affirming Care
- Sponsor
- University Hospital, Grenoble
- Start date
- 2024-09-27
- Primary completion
- 2025-02
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- France
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Being a trans masculine individual * Taking a gender affirming hormonal therapy (GAHT) * living close to Grenoble * having pelvic pain that appeared or were modified after taking GAHT Exclusion Criteria: * Subject under guardianship or subject deprived of liberty Refusal of voice recording
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06487754